Plasminogen Activator Inhibitor‐1 in the Pathophysiology of Late Life Depression.
Saved in:
| Title: | Plasminogen Activator Inhibitor‐1 in the Pathophysiology of Late Life Depression. |
|---|---|
| Authors: | Métivier, L., Vivien, D., Goy, R., Agin, V., Bui, E., Benbrika, S. |
| Source: | International Journal of Geriatric Psychiatry. Nov2024, Vol. 39 Issue 11, p1-14. 14p. |
| Subjects: | Mental depression risk factors, Adipokines, Health status indicators, Cellular aging, Apoptosis, Sedentary lifestyles, Geriatric psychiatry, Insulin, Tissue plasminogen activator, Blood coagulation factors, Antidepressants, Gene expression, Protease inhibitors, Aging, Fibrinolysis, Psychological stress, Cytokines, Inflammation, Cushing's syndrome, Mental depression, Drug resistance, Biomarkers, Interleukins, Old age |
| Abstract: | Introduction: Late life depression (LLD) is characterized by specific clinical features including a high frequency of vascular form and frequent antidepressant treatment resistance. The expression and functions of the serine protease inhibitor, Plasminogen Activator Inhibitor‐1 (PAI‐1) is known to be altered by aging, vascular damage, insulin levels associated with a sedentary lifestyle, chronic stress leading to hypercortisolemia, and inflammatory changes linked to stress responses. These phenomena would be implicated in LLD like vascular depression. This article thus aims to review the existing literature regarding the association between LLD and plasmatic levels of PAI‐1, a marker of hypofibrinolysis. We hypothesize that increased age would be associated with changes in PAI‐1 plasma level and function which influence LLD pathogenesis and its treatment. Results: Although a large number of studies on PAI‐1 changes in the elderly exist, studies about its implications in LLD are sparse. Despite heterogeneous findings regarding the direction of variation in plasmatic PAI‐1 levels among elderly participants with LLD, all studies demonstrated an association between PAI‐1 levels and current or remitted depressive symptoms. Moreover, disruptions in the concentrations of other biological markers influencing PAI‐1 expression, such as cytokines or adipokines, were also observed, notably an increase in the levels of interleukins 6 and 8. Discussion: LLD genesis appears to be influenced by PAI‐1 regulatory loops which are implicated in senescence or cell death. The resistance to antidepressant treatment appears to be linked to distinct biological profiles involving inflammatory and fibrinolytic factors. Taken together these data suggest that PAI‐1 pathway may be a promising target of treatment development efforts for LLD, and depression in general. [ABSTRACT FROM AUTHOR] |
| Copyright of International Journal of Geriatric Psychiatry is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 181108156 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Plasminogen Activator Inhibitor‐1 in the Pathophysiology of Late Life Depression. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Métivier%2C+L%2E%22">Métivier, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Vivien%2C+D%2E%22">Vivien, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Goy%2C+R%2E%22">Goy, R.</searchLink><br /><searchLink fieldCode="AR" term="%22Agin%2C+V%2E%22">Agin, V.</searchLink><br /><searchLink fieldCode="AR" term="%22Bui%2C+E%2E%22">Bui, E.</searchLink><br /><searchLink fieldCode="AR" term="%22Benbrika%2C+S%2E%22">Benbrika, S.</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22International+Journal+of+Geriatric+Psychiatry%22">International Journal of Geriatric Psychiatry</searchLink>. Nov2024, Vol. 39 Issue 11, p1-14. 14p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Mental+depression+risk+factors%22">Mental depression risk factors</searchLink><br /><searchLink fieldCode="DE" term="%22Adipokines%22">Adipokines</searchLink><br /><searchLink fieldCode="DE" term="%22Health+status+indicators%22">Health status indicators</searchLink><br /><searchLink fieldCode="DE" term="%22Cellular+aging%22">Cellular aging</searchLink><br /><searchLink fieldCode="DE" term="%22Apoptosis%22">Apoptosis</searchLink><br /><searchLink fieldCode="DE" term="%22Sedentary+lifestyles%22">Sedentary lifestyles</searchLink><br /><searchLink fieldCode="DE" term="%22Geriatric+psychiatry%22">Geriatric psychiatry</searchLink><br /><searchLink fieldCode="DE" term="%22Insulin%22">Insulin</searchLink><br /><searchLink fieldCode="DE" term="%22Tissue+plasminogen+activator%22">Tissue plasminogen activator</searchLink><br /><searchLink fieldCode="DE" term="%22Blood+coagulation+factors%22">Blood coagulation factors</searchLink><br /><searchLink fieldCode="DE" term="%22Antidepressants%22">Antidepressants</searchLink><br /><searchLink fieldCode="DE" term="%22Gene+expression%22">Gene expression</searchLink><br /><searchLink fieldCode="DE" term="%22Protease+inhibitors%22">Protease inhibitors</searchLink><br /><searchLink fieldCode="DE" term="%22Aging%22">Aging</searchLink><br /><searchLink fieldCode="DE" term="%22Fibrinolysis%22">Fibrinolysis</searchLink><br /><searchLink fieldCode="DE" term="%22Psychological+stress%22">Psychological stress</searchLink><br /><searchLink fieldCode="DE" term="%22Cytokines%22">Cytokines</searchLink><br /><searchLink fieldCode="DE" term="%22Inflammation%22">Inflammation</searchLink><br /><searchLink fieldCode="DE" term="%22Cushing's+syndrome%22">Cushing's syndrome</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+depression%22">Mental depression</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+resistance%22">Drug resistance</searchLink><br /><searchLink fieldCode="DE" term="%22Biomarkers%22">Biomarkers</searchLink><br /><searchLink fieldCode="DE" term="%22Interleukins%22">Interleukins</searchLink><br /><searchLink fieldCode="DE" term="%22Old+age%22">Old age</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Introduction: Late life depression (LLD) is characterized by specific clinical features including a high frequency of vascular form and frequent antidepressant treatment resistance. The expression and functions of the serine protease inhibitor, Plasminogen Activator Inhibitor‐1 (PAI‐1) is known to be altered by aging, vascular damage, insulin levels associated with a sedentary lifestyle, chronic stress leading to hypercortisolemia, and inflammatory changes linked to stress responses. These phenomena would be implicated in LLD like vascular depression. This article thus aims to review the existing literature regarding the association between LLD and plasmatic levels of PAI‐1, a marker of hypofibrinolysis. We hypothesize that increased age would be associated with changes in PAI‐1 plasma level and function which influence LLD pathogenesis and its treatment. Results: Although a large number of studies on PAI‐1 changes in the elderly exist, studies about its implications in LLD are sparse. Despite heterogeneous findings regarding the direction of variation in plasmatic PAI‐1 levels among elderly participants with LLD, all studies demonstrated an association between PAI‐1 levels and current or remitted depressive symptoms. Moreover, disruptions in the concentrations of other biological markers influencing PAI‐1 expression, such as cytokines or adipokines, were also observed, notably an increase in the levels of interleukins 6 and 8. Discussion: LLD genesis appears to be influenced by PAI‐1 regulatory loops which are implicated in senescence or cell death. The resistance to antidepressant treatment appears to be linked to distinct biological profiles involving inflammatory and fibrinolytic factors. Taken together these data suggest that PAI‐1 pathway may be a promising target of treatment development efforts for LLD, and depression in general. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of International Journal of Geriatric Psychiatry is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=181108156 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/gps.70015 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 1 Subjects: – SubjectFull: Mental depression risk factors Type: general – SubjectFull: Adipokines Type: general – SubjectFull: Health status indicators Type: general – SubjectFull: Cellular aging Type: general – SubjectFull: Apoptosis Type: general – SubjectFull: Sedentary lifestyles Type: general – SubjectFull: Geriatric psychiatry Type: general – SubjectFull: Insulin Type: general – SubjectFull: Tissue plasminogen activator Type: general – SubjectFull: Blood coagulation factors Type: general – SubjectFull: Antidepressants Type: general – SubjectFull: Gene expression Type: general – SubjectFull: Protease inhibitors Type: general – SubjectFull: Aging Type: general – SubjectFull: Fibrinolysis Type: general – SubjectFull: Psychological stress Type: general – SubjectFull: Cytokines Type: general – SubjectFull: Inflammation Type: general – SubjectFull: Cushing's syndrome Type: general – SubjectFull: Mental depression Type: general – SubjectFull: Drug resistance Type: general – SubjectFull: Biomarkers Type: general – SubjectFull: Interleukins Type: general – SubjectFull: Old age Type: general Titles: – TitleFull: Plasminogen Activator Inhibitor‐1 in the Pathophysiology of Late Life Depression. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Métivier, L. – PersonEntity: Name: NameFull: Vivien, D. – PersonEntity: Name: NameFull: Goy, R. – PersonEntity: Name: NameFull: Agin, V. – PersonEntity: Name: NameFull: Bui, E. – PersonEntity: Name: NameFull: Benbrika, S. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 08856230 Numbering: – Type: volume Value: 39 – Type: issue Value: 11 Titles: – TitleFull: International Journal of Geriatric Psychiatry Type: main |
| ResultId | 1 |